Trial result ·
Durability of cryoballoon ablation for eradication of neoplastic Barrett's esophagus: a multicenter prospective cohort study (with video).
Written based on 1 research study on PubMed, searched on 3 Nov 2026.
What was studied
This study looked at a balloon treatment called cryoballoon ablation. It was used for Barrett's esophagus with early cancer or pre-cancer changes. The changed lining was up to 6 cm long. Any spots that could be seen were first cut out with a scope. People were followed at 11 sites after their lining was fully cleared. The team checked if the changed tissue stayed gone.
What they found
Of 94 people treated in year 1, 88 had all changed tissue cleared. Of those, 76 took part in this follow-up study. The median follow-up was 4 years. The changed lining came back in 9 people. When it came back, the median time was 19 months. Early cancer in the lining showed up in 1 person. With repeat care, 75 of 76 people stayed clear. 4 people needed the esophagus stretched due to narrowing. In 2 of them, the narrowing was there before.
What it means for patients
The authors say the treatment was safe and worked very well. They say the results lasted for at least 3 years. This applies to people whose changed tissue was first fully cleared. Some people needed repeat care to keep the lining clear.
Why it is not certain yet
Only 76 people took part in this follow-up part. Not all people treated in year 1 joined it. Follow-up ran from 1 to 7.9 years, so some had less time. The study did not compare this with another treatment. Studies without a comparison group can only show so much.
The registered trial
The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.
Source
Durability of cryoballoon ablation for eradication of neoplastic Barrett's esophagus: a multicenter prospective cohort study (with video).
PubMed · PMID 41275893We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Gastric and oesophageal cancer publications